Current issue
Archive
Manuscripts accepted
About the journal
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
3/2020
vol. 73 abstract:
Review paper
The effects of serotonin inhibitors on bone metabolism: literature review
Rocco Franco
1
,
Asaro Matteo
2
,
Francesco Gianfreda
2
,
Michele Miranda
2
,
Patrizio Bollero
2
,
Alberta Barlattani
3
J Stoma 2020; 73, 3: 136-141
Online publish date: 2020/06/30
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Depression is a mood and behavior disorder. It is a very frequent pathology in the world that requires pharmacological treatment using drugs that inhibit the recovery of serotonin. In fact, serotonin is a hormone that creates a feeling of well-being at the level of central nervous system. Serotonin is mainly produced by nerve cells. Therefore, selective serotonin reuptake inhibitors (SSRIs) are mainly used for the treatment of states of anxiety and major depressive disorder. SSRIs increase serotonin level, blocking its resorption in the presynaptic cell. Consequently, an increase in the bioavailability of serotonin in the synaptic junction occur. In fact, at the bone level, according to some observations, it causes an increase in bone resorption. Our study with a systematic review of the literature was to evaluate whether the intake of SSRIs could in any way influence implant survival. “SSRI” and “dental implant” were used as key words in the principal resources. Five articles that met the inclusion criteria were considered. The study found that these drugs can affect the implant survival rate. The data of these articles concerning implant survival have extrapolated. There is an association between intake and implant survival, probably due to a possible link between bone metabolism and drug. Further studies are recommended to effectively evaluate the influence of the drug on implant survival.
keywords:
dental implant, selective serotonin reuptake inhibitor, implant success |